(Total Views: 261)
Posted On: 01/20/2022 8:25:50 AM
Post# of 54

$ONCY News Article - Oncolytics Biotech Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium https://marketwirenews.com/news-releases/onco...19226.html


My Twitter: WhyteStocks